ArticleMolecular oncology2024

An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancer.

Thomas Fleischer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.